Current Investment Portfolio
Our current investment portfolio includes partners like Arrivo BioVentures, Baebies, Bio 54, BioStable Science & Engineering, Emergo Therapeutics, KitCheck, Leiters, Phononic, Pryon and Rediscovery. From pharmacy kit processing and medication tracking software, to bio-technologies, cardiovascular technologies and more. We are investing in and fostering companies and technologies that advance the future of health.
Prior Investment Portfolio
Some of our prior investments include BardyDX, Gauss Surgical, Phynd, Target PharmaSolutions, Veran Medical Technologies, Midnight Pharma, Awarepoint and Aerial BioPharma. Rex Health Ventures is committed to innovation and partnering with emerging companies throughout North Carolina and the U.S.